News | March 05, 2024
Biocon Biologics secures Canada market entry date for YESAFILI
This agreement paves the way for the introduction of YESAFILI into the Canadian market
This agreement paves the way for the introduction of YESAFILI into the Canadian market
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
_256_384.png){kind=logo}
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
The newly developed adhesive is available in two different grades. Loctite WT 3001 and Loctite WT 3003 h
Three-point improvement achieved in Sex Ratio at Birth from 904 in 2017-19 to 907 in 2018-20
Subscribe To Our Newsletter & Stay Updated
